Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (7628)	12/28/2002 7:27:35 PM
From: nigel bates	Read Replies (1) \| Respond to of 52153

It is odd: the stock traded higher when there was real uncertainty about ODAC outcome. The outcome was extremely favorable to CRXA and the stock trades lower. I had thought that the market had already bet outcome would be negative... Take a look at how Vernalis traded after the approval of Frova. Sometimes the market offers a bargain which you shouldn't question too much. (edit) Admittedly there was a timelag before it really hit the bargain basement, but it was one of my few seriously profitable bios of 2002.